Oak Ridge Investments’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-213,891
Closed -$1.54M 174
2019
Q3
$1.54M Sell
213,891
-105,028
-33% -$754K 0.12% 116
2019
Q2
$2.54M Sell
318,919
-20,106
-6% -$238K 0.18% 109
2019
Q1
$4.26M Buy
339,025
+20,672
+6% +$327K 0.27% 108
2018
Q4
$6.35M Sell
318,353
-74,968
-19% -$1.73M 0.46% 83
2018
Q3
$11.2M Buy
+393,321
New +$9.38M 0.62% 67

Other funds holding EVH

Oak Ridge Investments's EVH Position: Q4 2019 in Review

Oak Ridge Investments sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 213,891 shares — an estimated $1.54M sold.

Oak Ridge Investments first reported a position in EVH in Q3 2018 and held it in 5 quarters. The position peaked at $11.2M in Q3 2018. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

  • Oak Ridge Investments reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
  • Oak Ridge Investments sold 213,891 Evolent Health shares in Q4 2019, an estimated $1.54M.
  • Oak Ridge Investments first reported a position in Evolent Health in Q3 2018 and held it in 5 quarters.
  • Oak Ridge Investments's Evolent Health position peaked at $11.2M in Q3 2018.
  • 167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Oak Ridge Investments's 13F filing for Q4 2019, filed 5 Feb 2020.